Like a tenacious bulldog, Roche Holding AG continues its determined effort to acquire Illumina, Inc., the company that makes gene sequencing systems. Last week, Roche increased its offer from $44.50 per share to $51 per share for Illumina stock. That raises the price Roche says it will pay to $6.5 billion, which is 15% greater …
April 2, 2012 “Intelligence: Late Breaking Lab News” Read More »
To access this post, you must purchase The Dark Report.